UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

Annals of the rheumatic diseases, 2009-05, Vol.68 (5), p.620-628

2009

Volltextzugriff (PDF)

The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture

Osteoporosis international, 2013-03, Vol.24 (3), p.811-823

2013

Volltextzugriff (PDF)

Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis

Rheumatology (Oxford, England), 2009-01, Vol.48 (1), p.61-64

2009

Volltextzugriff (PDF)

AB0299 The Reasons for Withdrawal of Biological Dmards According To The Russian Registry of Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1002

2016

Volltextzugriff (PDF)

Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations

Clinical and experimental rheumatology, 2008-05, Vol.26 (3), p.421

2008

Volltextzugriff (PDF)

AB0370 Results of pulmonary function tests and high resolution computed tomography of the lung in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.658-658

2013

Volltextzugriff (PDF)

How synthesis parameters influence the quality of lead magnesioniobate PbMg1/3Nb2/3O3

Russian journal of inorganic chemistry, 2012-06, Vol.57 (6), p.797-801

2012

Volltextzugriff (PDF)

Cardiac troponin and β-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis

Clinica chimica acta, 2001-04, Vol.306 (1), p.27-33

2001

Volltextzugriff (PDF)

Antiendothelial Cell Antibodies: Useful Markers of Systemic Sclerosis

The American journal of medicine, 1997-02, Vol.102 (2), p.178-185

1997

Volltextzugriff (PDF)

Soluble adhesion molecules in rheumatoid arthritis

Rheumatology (Oxford, England), 2000-07, Vol.39 (7), p.808-810

2000

Volltextzugriff (PDF)

AB0299 The Reasons for Withdrawal of Biological Dmards According To The Russian Registry of Patients with Rheumatoid Arthritis: Table 1

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1002-1002

2016

Volltextzugriff (PDF)

Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus

Lupus, 1995-02, Vol.4 (1), p.29-32

1995

Volltextzugriff (PDF)

The activated immune system and the renin–angiotensin–aldosterone system in congestive heart failure

Journal of internal medicine, 1998-02, Vol.243 (2), p.93-98

1998

Volltextzugriff (PDF)

Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis

Journal of rheumatology, 1997-04, Vol.24 (4), p.666

1997

Volltextzugriff (PDF)

Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis

Clinical chemistry (Baltimore, Md.), 1992-05, Vol.38 (5), p.678

1992

Volltextzugriff (PDF)

Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies

Clinical and Diagnostic Laboratory Immunology, 1997-09, Vol.4 (5), p.519

1997

Volltextzugriff (PDF)

Prolactin levels in men with SLE and RA

Journal of rheumatology, 1990-11, Vol.17 (11), p.1569

1990

Volltextzugriff (PDF)

Serum neopterin concentrations in Wegener's granulomatosis correlate with vasculitis activity

Clinical and experimental rheumatology, 1995-05, Vol.13 (3), p.353

1995

Volltextzugriff (PDF)

Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis

Rheumatology (Oxford, England), 1997-06, Vol.36 (6), p.656-660

1997

Volltextzugriff (PDF)

Anaphylatoxins in dilated cardiomyopathy

Journal of internal medicine, 1993-08, Vol.234 (2), p.139-142

1993

Volltextzugriff (PDF)

Musculoskeletal disorders in Russia at the end of the 20th century

Journal of rheumatology. Supplement, 2003-08, Vol.67, p.56

Nassonov, Evgeny L

2003

Volltextzugriff (PDF)

Elastin degradation in systemic vasculitis

Pathologie biologie (Paris), 1996-04, Vol.44 (4), p.254

1996

Volltextzugriff (PDF)

Serum neopterin in acute rheumatic fever

Clinical chemistry (Baltimore, Md.), 1993-04, Vol.39 (4), p.693

1993

Volltextzugriff (PDF)

Serum neopterin—possible immunological marker of myocardial inflammation in patients with dilated heart muscle disease

European heart journal, 1991-08, Vol.12 (suppl-D), p.151-153

1991

Volltextzugriff (PDF)

Role of β2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells

Lupus, 1995-06, Vol.4 (3), p.179-186

1995

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(44)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture

Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis

AB0299 The Reasons for Withdrawal of Biological Dmards According To The Russian Registry of Patients with Rheumatoid Arthritis

Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations

AB0370 Results of pulmonary function tests and high resolution computed tomography of the lung in patients with rheumatoid arthritis

How synthesis parameters influence the quality of lead magnesioniobate PbMg1/3Nb2/3O3

Cardiac troponin and β-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis

Antiendothelial Cell Antibodies: Useful Markers of Systemic Sclerosis

Soluble adhesion molecules in rheumatoid arthritis

AB0299 The Reasons for Withdrawal of Biological Dmards According To The Russian Registry of Patients with Rheumatoid Arthritis: Table 1

Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus

The activated immune system and the renin–angiotensin–aldosterone system in congestive heart failure

Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis

Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis

Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies

Prolactin levels in men with SLE and RA

Serum neopterin concentrations in Wegener's granulomatosis correlate with vasculitis activity

Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis

Anaphylatoxins in dilated cardiomyopathy

Musculoskeletal disorders in Russia at the end of the 20th century

Elastin degradation in systemic vasculitis

Serum neopterin in acute rheumatic fever

Serum neopterin—possible immunological marker of myocardial inflammation in patients with dilated heart muscle disease

Role of β2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells

Suchergebnisse filtern